---
nav_exclude: true
title: "Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=733848"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2023-02-16
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

This report describes up to 4 months of protection against COVID-19 among children aged 3-5 and 3-4 year who received monovalent primary series vaccinations.

## 詳細內容

This report describes up to 4 months of protection against COVID-19 among children aged 3-5 and 3-4 year who received monovalent primary series vaccinations.

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:11:27Z*
*資料來源: CDC MMWR*
